New NCCN Member Institution: Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute has been named the newest NCCN Member Institution; NCCN now has 26 Member Institutions serving patients throughout the United States.
FORT WASHINGTON, PA — The National Comprehensive Cancer Network ® ( NCCN ® ), an alliance of the world’s leading cancer centers dedicated to quality, effectiveness, and efficiency of cancer care so that patients can live better lives, today announced that Case Comprehensive Cancer Center which includes University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute has been elected to institutional membership. NCCN now has 26 Member Institutions serving patients throughout the United States.
“Case Comprehensive Cancer Center brings to NCCN unique and valuable attributes, including a robust genomics program and clinical research operational infrastructure, that indeed will enhance the already extraordinary collaboration of the alliance,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “We look forward to working with their renowned experts and leadership to further the NCCN mission, support and enhance evidence-based decision-making, and promote the importance of continuous process improvement.”
“I am excited to welcome Case Comprehensive Cancer Center to the NCCN alliance,” said Samuel M. Silver, MD, PhD, University of Michigan Comprehensive Cancer Center , Chair, NCCN Board of Directors. “Collaborating with their expert clinicians and researchers will indeed strengthen our network and improve the lives of patients with cancer.”
Case Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center located at Case Western Reserve University. The center, which has been continuously funded since 1987, integrates the cancer research activities of the largest biomedical research and health care institutions in Ohio – Case Western Reserve, University Hospitals (UH) Case Medical Center and the Cleveland Clinic. NCI-designated cancer centers are characterized by scientific excellence and the capability to integrate a diversity of research approaches to focus on the problem of cancer. It is led by Stanton Gerson, MD, Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology, and also Director of the National Center for Regenerative Medicine, Case Western Reserve, and Director of the Seidman Cancer Center at UH Case Medical Center.
“Our centers join an elite set of nationally recognized cancer centers that set the standards for exceptional cancer care, coordinated cancer services, and top-of-mind guidelines for patient management. We bring to the network well known national leaders in cancer care, clinical investigation, and translational research, and two highly ranked institutions for cancer care, Seidman Cancer Center and Taussig Cancer Institute, that will add to the capabilities and impact of NCCN. This is a group we are honored to join,” said Dr. Gerson.
Now in its 20th year of operation, originally announced as an alliance of 13 leading cancer centers in 1995, NCCN is devoted to patient care, research, and education in order to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology ( NCCN Guidelines ® ) are considered the standard of care and clinical policy by oncologists and payers. The most comprehensive clinical treatment guidelines in any area of medicine, the NCCN Guidelines® are developed through an explicit review of the evidence integrated with expert medical judgment and recommendations by multidisciplinary panels from NCCN Member Institutions.
For more information about NCCN, the NCCN Member Institutions, and the NCCN Guidelines, visit NCCN.org .
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
About Case Comprehensive Cancer Center
Case Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center located at Case Western Reserve University. The center, which has been continuously funded since 1987, integrates the cancer research activities of the largest biomedical research and health care institutions in Ohio – Case Western Reserve, University Hospitals (UH) Case Medical Center and the Cleveland Clinic. NCI-designated cancer centers are characterized by scientific excellence and the capability to integrate a diversity of research approaches to focus on the problem of cancer. It is led by Stanton Gerson, MD, Asa and Patricia Shiverick-Jane Shiverick (Tripp) Professor of Hematological Oncology, director of the National Center for Regenerative Medicine, Case Western Reserve, and director of the Seidman Cancer Center at UH Case Medical Center.
About University Hospitals
University Hospitals, the second largest employer in Northeast Ohio with 25,000 employees, serves the needs of patients through an integrated network of 15 hospitals, 29 outpatient health centers and primary care physician offices in 15 counties. At the core of our $3.5 billion health system is University Hospitals Case Medical Center, ranked among America’s 50 best hospitals by U.S. News & World Report in all 12 methodology-ranked specialties. The primary affiliate of Case Western Reserve University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and research centers of excellence in the nation, including cancer, pediatrics, women's health, orthopaedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. For more information, go to www.uhhospitals.org
About Cleveland Clinic
Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey. More than 3,000 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. The Cleveland Clinic health system includes a main campus near downtown Cleveland, eight community hospitals, more than 75 Northern Ohio outpatient locations, including 16 full-service Family Health Centers, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and, scheduled to begin seeing patients in 2015, Cleveland Clinic Abu Dhabi. In 2013, there were 5.5 million outpatient visits throughout the Cleveland Clinic health system and 157,000 hospital admissions. Patients came for treatment from every state and from more than 130 countries. Visit us at www.clevelandclinic.org . Follow us at www.twitter.com/ClevelandClinic .
About Taussig Cancer Institute
The Taussig Cancer Institute provides world-class cancer care enhanced by innovative basic, genetic and translational research. It offers the most effective techniques to achieve long-term survival and quality of life. The Taussig Cancer Institute’s more than 250 specialists care for approximately 30,000 patients a year, with access to a wide range of clinical trials. The Taussig Cancer Institute is one of 27 institutes at Cleveland Clinic, a nonprofit academic medical center ranked among the nation’s top hospitals (U.S. News & World Report) , where more than 3,000 physicians and researchers in 120 specialties collaborate to give every patient the best outcome and experience. clevelandclinic.org/cancer
Katie Kiley Brown, NCCN